Business Context and Reporting Period
Company: Kewaunee Scientific Corporation (KEQU)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended July 31, 2024
Business Overview: The Company designs, manufactures, and installs scientific and technical furniture, including laboratory cabinetry and fume hoods. Operations are divided into Domestic and International segments. The Company is a non-accelerated filer and a smaller reporting company.
Key Financial Metrics
| Metric ($ in thousands) | Q1 2024 | Q1 2023 |
|---|---|---|
| Net Sales | $48,393 | $49,839 |
| Gross Profit | $12,488 | $11,914 |
| Gross Margin | 25.8% | 23.9% |
| Operating Profit | $2,575 | $3,808 |
| Net Earnings (Attributable to Kewaunee) | $2,193 | $2,474 |
| Diluted EPS | $0.74 | $0.86 |
| Cash and Cash Equivalents | $24,211 | $23,267 |
| Working Capital | $56,012 | $56,037 |
| Order Backlog | $159.4 million | $140.8 million |
Liquidity & Debt: The Company maintains a Revolving Credit Facility with $10.8 million remaining capacity as of July 31, 2024. Total debt includes a financing liability of approximately $27.96 million related to a sale-leaseback transaction for its headquarters.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 2.9% year-over-year to $48.4 million. Domestic sales were relatively flat ($35.5M vs $35.4M), while International sales declined 10.7% to $12.9M due to customer construction site delays in India.
- Margin Expansion: Gross profit margin improved to 25.8% from 23.9%, driven by a favorable sales mix in Domestic operations compared to the prior year.
- Operating Expense Increase: Operating expenses rose to $9.9 million (20.5% of sales) from $8.1 million (16.3% of sales). Increases were attributed to higher SG&A wages, benefits, stock-based compensation, and consulting fees.
- Net Earnings Decline: Net earnings attributable to the Company decreased 11.4% to $2.2 million. This was despite a lower effective tax rate (7.9% vs 26.3%) driven by a discrete tax benefit of $421,000 from stock vesting.
- Cash Flow: Operating cash flow turned negative at $(0.8) million, compared to $8.2 million in the prior year, primarily due to decreases in accounts payable and other accrued expenses.
Outlook, Risks, and Management Commentary
- Backlog Strength: Order backlog increased to $159.4 million, up from $140.8 million in the prior year and $155.6 million at the end of the fiscal year.
- Outlook: Management notes that predicting future demand is limited due to the Company's role as a subcontractor. Earnings remain sensitive to raw material costs (steel, wood, epoxy resin) and the pace of laboratory construction projects.
- Risks: Key risks include international operations exposure (foreign currency fluctuations), supply chain disruptions, and dependence on customer delivery schedules. No material changes to risk factors were reported beyond those in the 10-K.
- Capital Allocation: The Company did not repurchase any shares during the quarter. The share repurchase program has 33,809 shares remaining authorized.
Investor Verification Checklist
- International Delays: Verify the status of construction projects in India and the expected timeline for the recovery of International sales.
- Operating Expense Run Rate: Assess whether the increase in SG&A and consulting fees is a one-time occurrence or a structural increase that may pressure future margins.
- Cash Flow Sustainability: Monitor the reversal of the negative operating cash flow trend, specifically the management of accounts payable and receivables.
- Backlog Conversion: Track the conversion rate of the $159.4 million backlog into recognized revenue in subsequent quarters.
- Debt Covenants: Confirm continued compliance with financial covenants under the Revolving Credit Facility, particularly given the interest rate environment.